Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia.

Herbaux C, Bertrand E, Marot G, Roumier C, Poret N, Soenen V, Nibourel O, Roche-Lestienne C, Broucqsault N, Galiègue-Zouitina S, Boyle EM, Fouquet G, Renneville A, Tricot S, Morschhauser F, Preudhomme C, Quesnel B, Poulain S, Leleu X.

Oncotarget. 2016 Jun 7;8(34):57451-57459. doi: 10.18632/oncotarget.9917. eCollection 2017 Aug 22.

2.

Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations.

Korfi K, Ali S, Heward JA, Fitzgibbon J.

Epigenetics. 2017 May 4;12(5):370-377. doi: 10.1080/15592294.2017.1282587. Epub 2017 Jan 20. Review.

PMID:
28106467
3.

Systemic Front Line Therapy of Follicular Lymphoma: When, to Whom and How.

Pavanello F, Steffanoni S, Ghielmini M, Zucca E.

Mediterr J Hematol Infect Dis. 2016 Nov 7;8(1):e2016062. eCollection 2016. Review.

4.

MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management.

Cai Q, Medeiros LJ, Xu X, Young KH.

Oncotarget. 2015 Nov 17;6(36):38591-616. doi: 10.18632/oncotarget.5774. Review.

5.

Comparison of RNA-seq and microarray-based models for clinical endpoint prediction.

Zhang W, Yu Y, Hertwig F, Thierry-Mieg J, Zhang W, Thierry-Mieg D, Wang J, Furlanello C, Devanarayan V, Cheng J, Deng Y, Hero B, Hong H, Jia M, Li L, Lin SM, Nikolsky Y, Oberthuer A, Qing T, Su Z, Volland R, Wang C, Wang MD, Ai J, Albanese D, Asgharzadeh S, Avigad S, Bao W, Bessarabova M, Brilliant MH, Brors B, Chierici M, Chu TM, Zhang J, Grundy RG, He MM, Hebbring S, Kaufman HL, Lababidi S, Lancashire LJ, Li Y, Lu XX, Luo H, Ma X, Ning B, Noguera R, Peifer M, Phan JH, Roels F, Rosswog C, Shao S, Shen J, Theissen J, Tonini GP, Vandesompele J, Wu PY, Xiao W, Xu J, Xu W, Xuan J, Yang Y, Ye Z, Dong Z, Zhang KK, Yin Y, Zhao C, Zheng Y, Wolfinger RD, Shi T, Malkas LH, Berthold F, Wang J, Tong W, Shi L, Peng Z, Fischer M.

Genome Biol. 2015 Jun 25;16:133. doi: 10.1186/s13059-015-0694-1.

6.

The tumor microenvironment shapes hallmarks of mature B-cell malignancies.

Shain KH, Dalton WS, Tao J.

Oncogene. 2015 Sep 3;34(36):4673-82. doi: 10.1038/onc.2014.403. Epub 2015 Feb 2. Review.

7.

Duodenal follicular lymphoma: comprehensive gene expression analysis with insights into pathogenesis.

Takata K, Tanino M, Ennishi D, Tari A, Sato Y, Okada H, Maeda Y, Goto N, Araki H, Harada M, Ando M, Iwamuro M, Tanimoto M, Yamamoto K, Gascoyne RD, Yoshino T.

Cancer Sci. 2014 May;105(5):608-15. doi: 10.1111/cas.12392. Epub 2014 Apr 6.

8.

Gene expression analysis in RA: towards personalized medicine.

Burska AN, Roget K, Blits M, Soto Gomez L, van de Loo F, Hazelwood LD, Verweij CL, Rowe A, Goulielmos GN, van Baarsen LG, Ponchel F.

Pharmacogenomics J. 2014 Apr;14(2):93-106. doi: 10.1038/tpj.2013.48. Epub 2014 Mar 4. Review.

9.

Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features.

Krijgsman O, Gonzalez P, Ponz OB, Roemer MG, Slot S, Broeks A, Braaf L, Kerkhoven RM, Bot F, van Groningen K, Beijert M, Ylstra B, de Jong D.

Haematologica. 2013 Dec;98(12):1921-9. doi: 10.3324/haematol.2013.085118. Epub 2013 Jul 12.

10.

Where medicine, business, and public policy intersect.

Wilson CL, Schultz S, Waldman SA.

Biotechnol Healthc. 2007 Feb;4(1):33-42.

11.

Pathogenesis of follicular lymphoma.

Kridel R, Sehn LH, Gascoyne RD.

J Clin Invest. 2012 Oct;122(10):3424-31. doi: 10.1172/JCI63186. Epub 2012 Oct 1. Review.

12.

High ratio of interfollicular CD8/FOXP3-positive regulatory T cells is associated with a high FLIPI index and poor overall survival in follicular lymphoma.

Saifi M, Maran A, Raynaud P, Picot MC, Quittet P, Cartron G, Rossi JF, Costes V.

Exp Ther Med. 2010 Nov;1(6):933-938. Epub 2010 Sep 1.

13.

Risk Factors of Follicular Lymphoma.

Ma S.

Expert Opin Med Diagn. 2012 Jul 1;6(4):323-333. Epub 2012 May 8.

14.

Host genetics in follicular lymphoma.

Cerhan JR.

Best Pract Res Clin Haematol. 2011 Jun;24(2):121-34. doi: 10.1016/j.beha.2011.02.004. Epub 2011 May 5. Review.

15.

An empirical assessment of validation practices for molecular classifiers.

Castaldi PJ, Dahabreh IJ, Ioannidis JP.

Brief Bioinform. 2011 May;12(3):189-202. doi: 10.1093/bib/bbq073. Epub 2011 Feb 7.

16.

Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.

Pangault C, Amé-Thomas P, Ruminy P, Rossille D, Caron G, Baia M, De Vos J, Roussel M, Monvoisin C, Lamy T, Tilly H, Gaulard P, Tarte K, Fest T.

Leukemia. 2010 Dec;24(12):2080-9. doi: 10.1038/leu.2010.223. Epub 2010 Oct 14.

17.

Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes.

Alvaro T, de la Cruz-Merino L, Henao-Carrasco F, Villar Rodríguez JL, Vicente Baz D, Codes Manuel de Villena M, Provencio M.

J Biomed Biotechnol. 2010;2010. pii: 846872. doi: 10.1155/2010/846872. Epub 2010 Aug 12. Review.

18.

A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients.

Gentles AJ, Alizadeh AA, Lee SI, Myklebust JH, Shachaf CM, Shahbaba B, Levy R, Koller D, Plevritis SK.

Blood. 2009 Oct 8;114(15):3158-66. doi: 10.1182/blood-2009-02-202465. Epub 2009 Jul 27.

19.

Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.

Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V, Gascoyne RD, Chan WC, Braziel RM, Rimsza LM, Weisenburger DD, Delabie J, Jaffe ES, Lister A, Fitzgibbon J, Staudt LM, Hartmann EM, Mueller-Hermelink HK, Campo E, Ott G, Rosenwald A.

Blood. 2009 Jul 23;114(4):826-34. doi: 10.1182/blood-2009-01-198580. Epub 2009 May 26.

20.

Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.

Borovecki A, Korać P, Nola M, Ivanković D, Jaksić B, Dominis M.

Croat Med J. 2008 Oct;49(5):625-35.

Supplemental Content

Support Center